Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘Alexion Pharmaceuticals Inc. (ALXN)’

Abbvie ABBV biopharmaceuticals cell blood dna gene stem test biotech research

Alexion Pharmaceuticals, Inc. (ALXN): Sound Shore Says the Pharmaceutical Company is Driving Innovation

Sound Shore posted 20 year annualized returns of 7.30% and 7.51% for its Sound Shore Fund Investor Class (SSHFX) and Institutional Class (SSHVX), respectively......(read more)
stocks, analysis, market, numbers, business, ticker, trade, money, price, investment, index, chart

Market Movers Today: CSRA Inc (CSRA), Ulta Beauty Inc (ULTA), Stamps.com (STMP), and More

CSRA Inc (NYSE:CSRA) (Bloomberg) General Dynamics Corp., the maker of Abrams tanks and nuclear submarines, is making a record bet on reinvigorating its......(read more)
stock, market, buy, graph, risk, trading, dice, concepts, chart, objects, investment, opportunity, business, three-dimensional, horizontal, line, gambling, decisions, symbol,

Check Out These 34 Stories To Find Out What’s Happening In The Financial Markets Today

1. U.S. Stock Market: “U.S. equities traded higher on Wednesday as investors cheered the Federal Reserve’s plan for scaling back its massive......(read more)
stock, stocks, market, marketing, shares, share, global, chart, bonds, tax, capital, concept, graph, growth, background, rise, statistics, economy, bar, future, loss, business,

32 Key News Stories from the World of Finance Today

1. U.S. Stock Market:   “The S&P 500 traded higher on Tuesday and nearly erased the losses suffered from the biggest sell-off of the year......(read more)
Biopharmaceutical, Bio-technology

Alexion Pharmaceuticals, Inc. (ALXN) Suffers Another Blow In The UK

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) has had another misfortune in the UK. The country’s public health watchdog, NICE (the National Institute......(read more)
people, person, lab, nuclear, hydrogen, concept, chemistry, technicians, researching, formula, chemists, biotechnology, researchers, discovery, weapon, samples,

10 Most Successful Innovative Companies in The World in 2016

Which are the most successful innovative companies in the world in 2016? Bringing something new to the table is something that seems to be difficult these......(read more)
Image Courtesy Pixabay

Today’s Trending Stocks: Pioneer, Ariad, Hershey, and 2 More

Crude futures are in the red today as sentiment around the commodity cools off. Meanwhile the Dow, Nasdaq, and S&P 500 are relatively flat as traders......(read more)
stock, graph, low, crash, down, arrow, risk, fall, crack, price, bad, market, debt, statistics, sales, economy, decline, failure, red, loss, business, concept, diagram, rates,

Stocks Not Having A Good Day: Catalent, Alexion Pharmaceuticals, DryShips, More

U.S stocks have edged higher on Tuesday following a rise in oil prices and Fed Chairwoman Janet Yellen’s speech on Monday, in which she maintained an......(read more)
dna, bio, clone, helix, medical, health, research, cell, gene, microscopic, render, tech, chemistry, molecular, liquid, life, biotechnology, technology, medicine, molecule,

Stumbling Biotech Stocks Spell Doom for Baker Bros. Advisors

While several hedge funds have suffered enormous losses this year due to their investments in biotech stocks, the performance of the leading biotech-focused......(read more)
Felix Baker - Baker Bros.

Healthcare-focused Baker Bros. Advisors’ Top Picks: Incyte, Alexion, ACADIA & More

Baker Bros. Advisors is a New York City-based fund launched in 2000 by Julian and Felix Baker. The firm focuses on life science and biotechnology companies......(read more)
money, expensive, medical, examination, patient, business, concept, clinic, stethoscope, wealth, insurance, finance, dollar, disease, bank, treatment, sick, medicine,

Hedge Funds Are Selling These 10 Large-Caps, Part 1

Professional money managers are quick to judge when things start to turn sour for a particular company. Generally, it would do retail investors well ......(read more)
Felix Baker - Baker Bros.

Top 5 Healthcare Bets of World-Class Baker Bros. Advisors

Baker Bros. Advisors is one of the most famous healthcare-focused equity hedge funds in the world today. It was founded in 2000 by brothers Julian Baker......(read more)
Abbvie ABBV biopharmaceuticals cell blood dna gene stem test biotech research

Mariner Investment Group’s Top Biotech Stock Picks For Q4

Mariner Investment Group is a New York-based investment advisory firm founded by William Michaelcheck in 1992. Apart from its headquarters in New York......(read more)
Health Practitioners

Don’t Miss White-Hot Baker Bros.’ New Healthcare Picks

At Insider Monkey, we track over 700 hedge funds and investment companies, which allows us to understand the market sentiment towards any given stock.......(read more)
pharma 3

Synageva Biopharma Corp (GEVA) Acquisition Helps Baker Bros. Advisors Top All Others In Q2 Returns

With the rapid pace of M&A happening in the biotechnology sector, Julian Baker and Felix Baker‘s Baker Bros. Advisors is making a habit of hitting......(read more)
Best Paying Medical Jobs with Least Education

What The Smart Money Thinks Of Barclays’ Top Healthcare Picks: Alexion Pharmaceuticals, Inc. (ALXN), Baxter International Inc (BAX), & Valeant Pharmaceuticals Intl Inc (VRX)

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), Baxter International Inc (NYSE:BAX), and Valeant Pharmaceuticals Intl Inc (NYSE:VRX) are among the top healthcare......(read more)
ynageva BioPharma Corp (NASDAQ:GEVA)

The ‘Smart Money’ Loves The 500% Upside On This Biopharma Stock

Orphan drugs, those treating rare conditions for small segments of the population, do not normally get much attention compared with the likes of a $12......(read more)
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)

Alexion Pharmaceuticals, Inc. (ALXN), Pharmacyclics, Inc. (PCYC), Aegerion Pharmaceuticals, Inc. (AEGR), Raptor Pharmaceutical Corp. (RPTP): Have These Four Biotechs Peaked?

Biotechnology stocks often trade with excessive valuations, until one day, large losses occur. The best way to protect yourself is to be logical when......(read more)
NPS Pharmaceuticals, Inc. (NASDAQ:NPSP)

NPS Pharmaceuticals, Inc. (NPSP), Eli Lilly & Co. (LLY), Alexion Pharmaceuticals, Inc. (ALXN): Three Justifications for the High Cost of Gattex

NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) has priced its Gattex drug for short bowel syndrome, or SBS, at $295,000, expecting to make peak sales of $350......(read more)
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)

Alexion Pharmaceuticals, Inc. (ALXN), Amgen, Inc. (AMGN), Baxter International Inc. (BAX): The Treatment of Rare Diseases Offers Unique Opportunities

A company with a modus operandi of tackling rare and very rare diseases might not necessarily jump out as a great investment, but this company has......(read more)
Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

Should You Buy Regeneron Pharmaceuticals Inc (REGN)?

Is Regeneron Pharmaceuticals Inc (NASDAQ:REGN) a good investment? If you were to ask many investors, hedge funds are viewed as delayed, outdated investment......(read more)
Vertex Pharmaceuticals Incorporated

What Hedge Funds Think About Vertex Pharmaceuticals Incorporated (VRTX)

Is Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) a buy? In the 21st century investor’s toolkit, there are tons of metrics market participants can......(read more)
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)

Do Hedge Funds and Insiders Love Alexion Pharmaceuticals, Inc. (ALXN)?

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) investors are standing pat. In the 21st century investor’s toolkit, there are dozens of indicators investors......(read more)
Amgen, Inc. (NASDAQ:AMGN)

Hedge Funds Are Buying Amgen, Inc. (AMGN)

Who’s buying Amgen, Inc. (NASDAQ:AMGN)? To the average investor, there are tons of metrics shareholders can use to analyze stocks. Some of the......(read more)
Biogen Idec Inc (NASDAQ:BIIB)

This Biogen Idec Inc. (BIIB) Data is Screaming ‘Buy, Buy, Buy’

Biogen Idec Inc. (NASDAQ:BIIB) investors: listen up. To many market players, hedge funds are assumed to be overrated, old investment vehicles of a forgotten......(read more)
Celgene Corporation (NASDAQ:CELG)

Is Celgene Corporation (CELG) Going to Burn You?

Will Celgene Corporation (NASDAQ:CELG) burn you? Here’s some data to help answer that question. To many traders, hedge funds are perceived as overrated......(read more)
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)

Alexion Pharmaceuticals, Inc. (ALXN), Sarepta Therapeutics Inc (SRPT), Regeneron Pharmaceuticals Inc (REGN): Is There Any Remaining Value in This Industry Leader?

At some point, a company reaches a level of maximum valuation. It doesn’t mean the company becomes bad, but rather all upside is priced in and future......(read more)
Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX)

Onyx Pharmaceuticals, Inc. (ONXX), Amgen, Inc. (AMGN), Alexion Pharmaceuticals, Inc. (ALXN): Biotech’s Falling Fortunes Stymie Osiris Therapeutics, Inc. (OSIR)’s Huge Week

Biotech’s the biggest boom-or-bust business on the market, with regulatory approvals and clinical trial results routinely sending stocks hurtling......(read more)
Walter Energy, Inc. (NYSE:WLT)

Walter Energy, Inc. (WLT), Alexion Pharmaceuticals, Inc. (ALXN), Spirit AeroSystems Holdings, Inc. (SPR): Are These Takeover Rumors Good Buys?

When a company is acquired, the acquirer pays a large premium to where the acquired company’s stock price had previously been trading. Because of this......(read more)
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)

Alexion Pharmaceuticals, Inc. (ALXN), Onyx Pharmaceuticals, Inc. (ONXX): Will This Orphan Drug Maker Find a New Home?

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), already quite expensive, spiked higher since takeover rumors surfaced in early July. But can a deal give......(read more)
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)

Inovio Pharmaceuticals Inc (INO), Alnylam Pharmaceuticals, Inc. (ALNY): This Company Is in a Perfect Position to Take-off

In 2013, a number of new drugs got approvals from the FDA. This provided a boost to the biotech industry as a whole. Now, this speculative growth market......(read more)
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)

Alexion Pharmaceuticals, Inc. (ALXN), Onyx Pharmaceuticals, Inc. (ONXX): This Orphan Drug Company Only Appears Expensive

In the last couple of months, we saw two big offers being made – and rejected – in the biotech sector. Both times, the companies that rejected......(read more)
Cubist Pharmaceuticals Inc (NASDAQ:CBST)

Cubist Pharmaceuticals Inc (CBST), Trius Therapeutics, Inc. (TSRX): This Week in Biotech

With the SPDR S&P Biotech Index up 43% over the trailing-12-month period, it’s evident that investment dollars are willingly flowing into the......(read more)
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)

Alexion Pharmaceuticals, Inc. (ALXN), BioMarin Pharmaceutical Inc. (BMRN): 5 of the World’s Most Ultra-Rare Diseases

There are few times when your doctor or physician will utter the phrase, “I don’t know” to a patient, but when you’re dealing......(read more)
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)

Alexion Pharmaceuticals, Inc. (ALXN), Celgene Corporation (CELG): Biotech Favorites With Noteworthy Drug Data

Three of the biggest names in biotechnology have reported earnings, and their quarters involved very important drug-related information for investors.......(read more)
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)

Alexion Pharmaceuticals, Inc. (ALXN): Extremely Expensive Drugs for Extremely Rare Diseases

The biotech industry is known for fast paced acquisitions and rapid market consolidation. Larger pharmaceutical companies headed towards patent cliffs......(read more)
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)

Alexion Pharmaceuticals, Inc. (ALXN), Eli Lilly & Co. (LLY): Five Drugmakers With a Lot on the Line

You may or may not have heard, but it’s earnings season again. Contrary to popular belief, earnings season does actually take a break for a few......(read more)
Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

Regeneron Pharmaceuticals Inc (REGN), Alexion Pharmaceuticals, Inc. (ALXN): Is This Biopharmaceutical Company Ahead Of Its Time?

In most cases, a biopharmaceutical company chooses to develop either high-priced orphan-designated drugs, or therapeutics to treat large patient populations......(read more)
GameStop Corp. (NYSE:GME)

GameStop Corp. (GME): Three Stocks to Get on Your Watchlist

I follow quite a lot of companies, so the usefulness of a watchlist to me cannot be overstated. Without my watchlist, I’d be unable to keep up on......(read more)
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)

Onyx Pharmaceuticals, Inc. (ONXX), Alexion Pharmaceuticals, Inc. (ALXN): 3 Biotechs That Could Be Bought Out This Year

Buyout! The word gets biotech investors’ blood flowing and their hearts racing. Mere rumors that a biotech stock could get bought out can send shares......(read more)
Questcor Pharmaceuticals Inc (NASDAQ:QCOR)

Questcor Pharmaceuticals Inc (QCOR): Close To New Highs, Should You Like This Biotech?

Questcor Pharmaceuticals Inc (NASDAQ:QCOR) has a particularly fascinating history, having been at the center of controversy for the better part of its......(read more)

Celldex Therapeutics, Inc. (CLDX): 4 Reasons This Biotech Went up by 400 Percent

Celldex Therapeutics, Inc. (NASDAQ:CLDX), the first antibody-based immunotherapy company, has been a strong buy recommended by several analysts for some......(read more)
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)

Alexion Pharmaceuticals, Inc. (ALXN): Is Big Pharma Crazy for Chasing This Deal?

According to a Bloomberg report, Roche is prepared to offer $130 a share to purchase Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN). In other words, Roche......(read more)
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)

Alnylam Pharmaceuticals, Inc. (ALNY)’s Surge Caps Off a Strong Week in Biotech

Biotech’s the biggest boom-or-bust business on the market, with regulatory approvals and clinical trial results routinely sending stocks hurtling......(read more)
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)

Inovio Pharmaceuticals Inc (INO), Alnylam Pharmaceuticals, Inc. (ALNY): This Week in Biotech

With the SPDR S&P Biotech Index up 33% over the trailing-12-month period, it’s evident that investment dollars are willingly flowing into the......(read more)
NPS Pharmaceuticals, Inc. (NASDAQ:NPSP)

Aegerion Pharmaceuticals, Inc. (AEGR), NPS Pharmaceuticals, Inc. (NPSP): Three of the World’s Rarest Diseases (and the Uncommon Profits They Bring)

Imagine finding out that you have a disease that only a handful of people around the world have. Kirstie and Catherine Fields don’t have to imagine......(read more)
Largest Financial Services Companies

Wells Fargo & Co (WFC), Baxter International Inc. (BAX): Obamacare-Inspired Investment Opportunities

Love it or hate it, the Patient Protection and Affordable Care Act — commonly referred to as Obamacare — changes the health care landscape......(read more)
Dendreon Corporation (NASDAQ:DNDN)

Dendreon Corporation (DNDN), Johnson & Johnson (JNJ), Medivation Inc (MDVN): The Most Expensive Drugs in the World

The prescription-drug market currently generates a whopping $950 billion in annual sales, and that figure is likely to grow to $1.2 trillion by 2016.......(read more)
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)

Alexion Pharmaceuticals, Inc. (ALXN), BioMarin Pharmaceutical Inc. (BMRN): What Makes a Good Orphan Drug Investment?

Orphan drug companies are an exciting new class in the healthcare sector — with good and bad investment opportunities — let’s look at......(read more)
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)

Alexion Pharmaceuticals, Inc. (ALXN), Harman International Industries Inc./DE/ (HAR): Today’s 3 Best Stocks

It’s truly been a bizarre day, with the broad-based S&P 500 (INDEXSP:.INX) rallying in excess of 1% after economic data came in worse than expected......(read more)